Additionally, miR-185 was found to inhibit proliferation and cell cycle progression and induce apoptosis and autophagy in HCC cells by targeting different genes in the Akt signaling pathway, including AKT1, RICTOR and RHEB [77]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.